A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjects
Clinical trial NCT06350812 · COMPLETED
Trial details
- NCT number
- NCT06350812
- Sponsor
- PegBio Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-27
- Primary completion
- 2024-11-16
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.